Home›Stock Screener›Phaarmasia›Financial Statements

Phaarmasia Complete Financial Statements

11 Years of Data
2025 - 2015

In FYNone, Phaarmasia (PHRMASI) reported revenue ₹65 Cr, net profit ₹18 Cr and EPS ₹26.00, with a net profit margin of -8.0% and ROE of -22.2%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore PHRMASI intrinsic value to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -8.00% 2025 data
EBITDA Margin -4.00% 2025 data
Operating Margin -8.00% 2025 data
Return on Assets -9.09% 2025 data
Return on Equity -22.22% 2025 data

Balance Sheet Ratios

Equity Ratio 40.91% 2025 data
Asset Turnover 1.14 2025 data

PHRMASI Revenue, Net Profit & EBITDA — Year-on-Year Growth

PHRMASI YoY (March 2025 vs Period) — revenue +160.0%, net profit +1000.0%, EBITDA +2300.0%, expenses +65.4%. Review PHRMASI price earnings ratio to evaluate earnings-based valuation against sector peers.

Revenue Growth
+160.0%
Year-over-Year
Net Profit Growth
+1000.0%
Year-over-Year
EBITDA Growth
+2300.0%
Year-over-Year
Expense Growth
+65.4%
Year-over-Year
Assets Growth
-29.0%
Year-over-Year
Equity Growth
-10.0%
Year-over-Year

PHRMASI Income Statement — Revenue, EBITDA & Net Profit

Phaarmasia revenue ₹65 Cr, EBITDA ₹22 Cr, net profit ₹18 Cr, EPS ₹26.00 (None) — net profit margin -8.0%. For live price, earnings ratios and company overview, see Phaarmasia share price today.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 65 25 31 28 18 21 25 25 21 15 22 19
Expenses 43 26 31 29 19 20 24 24 20 14 21 18
EBITDA 22 -1 0 -1 -1 1 1 1 1 1 1 1
Operating Profit Margin % 1.00% -8.00% -3.00% -6.00% -10.00% 0.00% 3.00% 3.00% 3.00% 1.00% 1.00% 5.00%
Depreciation 0 0 0 0 0 0 0 1 1 0 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 21 -2 -1 -1 -2 1 1 1 1 0 0 0
Tax 4 0 0 0 0 0 0 0 0 0 0 0
Net Profit 18 -2 -1 -1 -2 0 1 1 1 0 0 0
Earnings Per Share (₹) 26.00 -2.33 -0.76 -1.84 -2.27 0.46 0.79 1.14 0.84 0.24 0.06 0.20

PHRMASI Balance Sheet — Assets, Liabilities & Shareholders' Equity

PHRMASI total assets ₹22 Cr, total equity ₹9 Cr, total liabilities ₹ Cr (2025) — ROE -22.2%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 22 31 28 21 22 34 33 22 20 19 19
Current Assets 8 18 15 8 9 20 19 8 6 4 4
Fixed Assets 12 13 13 13 13 13 14 14 14 14 16
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 9 19 16 8 9 20 20 8 6 5 4
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 0 0 1 1 1 1 1 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 9 10 11 12 14 13 13 12 12 12 13
Share Capital 7 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus 2 4 4 5 7 7 6 5 5 5 6

PHRMASI Cash Flow Statement — Operating, Investing & Financing

Phaarmasia operating cash flow ₹0 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 0 0 1 0 0 0 0 1 0 0 1
Investing Activities 0 0 0 0 0 0 0 -1 0 0 0
Financing Activities 0 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 1 0 0 0 0 0 0 0 0